Skip to main content
. 2022 May 18;17:2283–2299. doi: 10.2147/IJN.S360740

Figure 1.

Figure 1

(A) particle size (PS), (B) polydispersity index (PDI), (C) zeta potential (ZP), (D) drug content of ciprofloxacin and natamycin, and (E) entrapment efficiency (EE) of ciprofloxacin and natamycin for F1 formulation over three months storage at 4°C and 25°C (mean ± SD, n = 3).